Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darragh Duffy

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Med (New York, N.Y.)|August 20, 2021
A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditisCamille de Cevins, Marine Luka, Nikaïa Smith, et al.
Frontiers in Immunology|November 30, 2020
Systems Biology Methods Applied to Blood and Tissue for a Comprehensive Analysis of Immune Response to Hepatitis B Vaccine in AdultsRym Ben-Othman, Bing Cai, Aaron C Liu, et al.
The Journal of Experimental Medicine|July 18, 2024
SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiencyYi-Hao Chan, Vanja Lundberg, Jérémie Le Pen, et al.
Nature Communications|December 21, 2017
Type I interferon-mediated autoinflammation due to DNase II deficiencyMathieu P Rodero, Alessandra Tesser, Eva Bartok, et al.
Annals of the Rheumatic Diseases|December 15, 2025
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndromeClémence David, Nadia Nathan, Eslam Al-Abadi, et al.
Cell|May 7, 2026
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infectionsMorgane Fournier, Matthias Vanderkerken, Karim Dorgham, et al.
The Journal of Experimental Medicine|July 9, 2026
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosisDiana Olguín Calderón, Laura E Kilpatrick, Clément Conil, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Science (New York, N.Y.)|September 25, 2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Qian Zhang, Paul Bastard, Zhiyong Liu, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Med (New York, N.Y.)|August 20, 2021
A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditisCamille de Cevins, Marine Luka, Nikaïa Smith, et al.
Frontiers in Immunology|November 30, 2020
Systems Biology Methods Applied to Blood and Tissue for a Comprehensive Analysis of Immune Response to Hepatitis B Vaccine in AdultsRym Ben-Othman, Bing Cai, Aaron C Liu, et al.
The Journal of Experimental Medicine|July 18, 2024
SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiencyYi-Hao Chan, Vanja Lundberg, Jérémie Le Pen, et al.
Nature Communications|December 21, 2017
Type I interferon-mediated autoinflammation due to DNase II deficiencyMathieu P Rodero, Alessandra Tesser, Eva Bartok, et al.
Annals of the Rheumatic Diseases|December 15, 2025
Insights from a novel monogenic autoinflammatory disease: overview of a multicentric European cohort of 38 patients with COPA syndromeClémence David, Nadia Nathan, Eslam Al-Abadi, et al.
Cell|May 7, 2026
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infectionsMorgane Fournier, Matthias Vanderkerken, Karim Dorgham, et al.
The Journal of Experimental Medicine|July 9, 2026
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosisDiana Olguín Calderón, Laura E Kilpatrick, Clément Conil, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Science (New York, N.Y.)|September 25, 2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Qian Zhang, Paul Bastard, Zhiyong Liu, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 19